Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J9211 Idarubicin hcl injection

J Codes (Drugs)

Also known as: idarubicin, Idamycin

Intravenous injection of idarubicin hydrochloride, an anthracycline topoisomerase II inhibitor.

In Plain Language

red chemotherapy drug; acute leukemia treatment

Clinical Context

Used for acute myeloid leukemia and acute lymphoblastic leukemia.

RVU Information

CPT J9211 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

Hematology/OncologyMedical Oncology

Frequently Asked Questions

What is CPT code J9211?

CPT J9211 (Idarubicin hcl injection) is a J Codes (Drugs) code. Intravenous injection of idarubicin hydrochloride, an anthracycline topoisomerase II inhibitor.

How is J9211 administered?

CPT J9211 is administered by a healthcare provider, typically via injection or infusion. Used for acute myeloid leukemia and acute lymphoblastic leukemia. It is used by Hematology/Oncology, Medical Oncology.

When is CPT J9211 used?

Used for acute myeloid leukemia and acute lymphoblastic leukemia.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and export board-ready case logs — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.